Non-melanoma skin cancer. (Q34099783)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20171403%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Non-melanoma skin cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20171403%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20171403%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Vishal Madan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20171403%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Rolf-Markus Szeimies

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20171403%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

1 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20171403%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20171403%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

375

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20171403%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

9715

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20171403%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

673-685

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20171403%20AND%20SRC:MED&resulttype=core&format=json

The epidemiology of skin cancer

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Skin cancer trends in Northern Ireland and consequences for provision of dermatology services.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Low density lipoprotein receptor and cation-independent mannose 6-phosphate receptor are transported from the cell surface to the Golgi apparatus at equal rates in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Variations in registration of skin cancer in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Changing trends in non-melanoma skin cancer in South Wales, 1988-98.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Skin cancer incidence and the ageing population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Basal cell carcinoma on the trunk is associated with excessive sun exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

1 reference

7 January 2021

The health impact of solar radiation and prevention strategies: Report of the Environment Council, American Academy of Dermatology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

A dose-response curve for sun exposure and basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Does intermittent sun exposure cause basal cell carcinoma? a case-control study in Western Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

How different wavelengths of the ultraviolet spectrum contribute to skin carcinogenesis: the role of cellular damage responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Cellular and sub-cellular responses to UVA in relation to carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

β-Papillomavirus Infection and Skin Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

The role of immunosuppression in the pathogenesis of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

A population-based study of skin cancer incidence and prevalence in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Cutaneous malignancy and human immunodeficiency virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Non-Hodgkin lymphoma and skin cancer: A dangerous combination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

PUVA and cancer: a large-scale epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Reported use of photosensitizing medications and basal cell and squamous cell carcinoma of the skin: results of a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Occupational skin cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Occupation and keratinocyte cancer risk: a population-based case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Tobacco smoking, snuff dipping and the risk of cutaneous squamous cell carcinoma: a nationwide cohort study in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Basal cell carcinoma: from host response and polymorphic variants to tumour suppressor genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Biochemical evidence that patched is the Hedgehog receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Ultraviolet responses of Gorlin syndrome primary skin cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Allelic loss at Drosophila patched gene is highly prevalent in Basal and squamous cell carcinomas of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Wild-type p53 is a cell cycle checkpoint determinant following irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

p53 and the pathogenesis of skin cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Roles of the transcription factor p53 in keratinocyte carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Value of p53 protein in biological behavior of basal cell carcinoma and in normal epithelia adjacent to carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

The reactivation of telomerase activity in cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Telomerase activity of basal cell carcinoma in patients living in North Queensland, Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Why classify basal cell carcinomas?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

1 reference

7 January 2021

Correlation of embryonic fusion planes with the anatomical distribution of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Embryologic fusion planes: a plea for more precise analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Cutaneous basal cell carcinomas: distinct host factors are associated with the development of tumors on the trunk and on the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Malignant transformation of solar keratoses to squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

The risk of progression to invasive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Epidemiology of actinic keratoses and squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Guidelines for management of Bowen's disease: 2006 update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Noninvasive diagnostic tools for nonmelanoma skin cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Fluorescence lifetime imaging distinguishes basal cell carcinoma from surrounding uninvolved skin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Defining patients with high-risk cutaneous squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Prognostic factors for metastasis in squamous cell carcinoma of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Guidelines of care for cutaneous squamous cell carcinoma. Committee on Guidelines of Care. Task Force on Cutaneous Squamous Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Skin cancer of the head and neck with clinical perineural invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Nonmelanoma skin cancer and risk for subsequent malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Evaluation of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Time to rethink TNM staging in cutaneous SCC

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Guidelines for the management of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Interventions for basal cell carcinoma of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Interventions for preventing non-melanoma skin cancers in high-risk groups

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Surgical treatment of basal cell carcinomas using standard postoperative histological assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Do basal cell carcinomas recur after complete conventional surgical excision?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Treatment of basal cell carcinoma by dermatologists in the United Kingdom. British Association of Dermatologists Audit Subcommittee and the British Society for Dermatological Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ with a high-energy pulsed carbon dioxide laser

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Superpulsed CO2 laser treatment of basal cell carcinoma with intraoperatory histopathologic and cytologic examination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Vascular based non conventional dye laser treatment for basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Long-term results of irradiation for basal cell carcinoma of the skin of the nose.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

The important role of radiotherapy in patients with non-melanoma skin cancer and other cutaneous entities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Dermatological high-dose-rate brachytherapy for the treatment of basal and squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Radiation-sensitive genetically susceptible pediatric sub-populations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

The effect of 5-fluorouracil on inhibition of epidermal DNA synthesis in vivo: a comparison of the effect of formulations and a prodrug of 5-FU

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Imiquimod in basal cell carcinoma: how does it work?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Photodynamic therapy for nonmelanoma skin cancers. Current review and update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Guidelines for topical photodynamic therapy: update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Photodynamic therapy for the treatment of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Systemic photodynamic therapy with Photofrin for naevoid basal cell carcinoma syndrome-A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Solasodine glycoalkaloids: a novel topical therapy for basal cell carcinoma. A double-blind, randomized, placebo-controlled, parallel group, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Towards a more specific therapy: targeting nonmelanoma skin cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

Fluorouracil for allergic reactions to capecitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961196-X

7 January 2021

10.1016/S0140-6736(09)61196-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20171403%20AND%20SRC:MED&resulttype=core&format=json

release_64tqvnvjjnhdzbjl55dkinuxdi

18 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/64tqvnvjjnhdzbjl55dkinuxdi

24 November 2022

mapped directly with Wikidata item

1 reference